U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07104344) titled 'Study of CM355 in Patients With Systemic Lupus Erythematosus' on July 29.
Brief Summary: This study was designed to investigate the safety and efficacy of CM355 in patients with refractory SLE.
Study Start Date: Sept. 25
Study Type: INTERVENTIONAL
Condition:
Systemic Lupus Erythematosus
Intervention:
BIOLOGICAL: CM355
CM355 injection
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Second Xiangya Hospital of Central South University
Disclaimer: Curated by HT Syndication....